Tetraphase pharmaceuticals inc (TTPH)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
Revenues:
Total revenue

1,755

1,690

3,340

1,073

1,273

4,283

1,151

11,579

1,891

2,528

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Expenses:
Total revenues

-

-

-

-

-

-

-

-

-

-

4,067

1,586

1,485

1,090

850

1,243

1,962

2,471

2,856

3,343

3,016

3,072

2,294

1,275

2,457

1,898

2,166

3,722

2,700

3,240

2,537

1,316

507

Research and development

1,893

2,534

5,348

8,166

6,737

10,717

11,665

14,370

18,127

18,469

28,777

28,513

25,947

19,305

17,190

13,746

13,523

15,016

16,972

22,907

18,873

19,727

13,188

16,513

12,504

10,494

9,992

6,924

4,098

4,613

4,419

4,261

4,001

Selling, general and administrative

10,668

9,266

11,350

15,113

13,314

14,727

9,481

7,165

5,705

7,877

5,600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total expenses

14,019

13,232

17,678

23,685

20,313

25,672

21,146

21,535

23,832

26,346

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

-

-

-

-

-

-

-

-

-

-

-

5,065

5,133

4,341

4,858

4,759

5,253

5,587

3,937

6,489

4,903

3,728

3,086

2,947

3,171

2,327

1,860

1,756

1,225

1,329

1,017

1,002

961

Total operating expenses

-

-

-

-

-

-

-

-

-

-

34,377

33,578

31,080

23,646

22,048

18,505

18,776

20,603

20,909

29,396

23,776

23,455

16,274

19,460

15,675

12,821

11,852

8,680

5,323

5,942

5,436

5,263

4,962

Loss from operations

-12,264

-11,542

-14,338

-22,612

-19,040

-21,389

-19,995

-9,956

-21,941

-23,818

-30,310

-31,992

-29,595

-22,556

-21,198

-17,262

-16,814

-18,132

-18,053

-26,053

-20,760

-20,383

-13,980

-18,185

-13,218

-10,923

-9,686

-4,958

-2,623

-2,702

-2,899

-3,947

-4,455

Other income and expenses
Loss on extinguishment of debt

-

-

-1,568

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

71

83

-

250

-

-

-

-

-

-

302

181

137

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

69

87

252

416

507

532

437

413

365

343

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

-

3

2

-

-

-

-

-

Interest expense

-

0

650

975

955

624

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

334

385

433

470

431

369

202

216

234

Other income (expense)

-

-

-

-

-

-

-

-

-

-

-

-

-

95

88

94

73

16

9

10

-226

-

-

-

24

0

0

0

263

-

23

-105

-

Other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-167

-226

-278

-305

-380

-430

-468

-168

-350

-179

-321

-234

Net loss

-12,124

-11,372

-16,304

-22,921

-19,488

-21,481

-19,558

-9,543

-21,576

-23,475

-30,008

-31,811

-29,458

-22,461

-21,110

-17,168

-16,741

-18,116

-18,044

-26,043

-20,986

-20,550

-14,206

-18,463

-13,523

-11,303

-10,116

-5,426

-2,791

-3,052

-3,078

-4,268

-4,689

Net loss per share-basic and diluted

-1.31

-2.75

-6.00

-8.45

-7.25

-8.00

-7.39

-0.18

-0.42

-0.46

-0.63

-0.83

-0.79

-0.60

-0.58

-0.47

-0.46

-0.49

-0.49

-0.72

-0.66

-0.70

-0.55

-0.71

-0.53

0.48

-0.49

-0.26

-1.51

-23.97

-9.63

-13.42

-0.52

Weighted-average number of common shares used in net loss per share-basic and diluted

9,273

4,150

-99,900

105,331

2,687

-95,583

2,647

51,839

51,601

51,615

47,347

38,273

37,093

36,897

36,692

36,629

36,598

36,624

36,463

36,207

31,750

29,682

25,967

25,845

25,734

23,563

20,674

20,575

1,848

-8,308

320

318

8,938

Comprehensive loss

-12,124

-11,372

-16,304

-22,921

-19,488

-21,481

-19,558

-9,543

-21,576

-23,475

-30,008

-31,811

-29,458

-22,461

-21,110

-17,168

-16,741

-18,116

-18,044

-26,043

-20,986

-20,550

-14,206

-18,463

-13,523

-11,303

-10,116

-5,426

-2,791

-3,052

-3,078

-4,268

-4,689

Product Revenue, net [Member]
Total revenue

1,755

1,460

978

796

341

178

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of revenue

1,360

1,334

882

307

164

130

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License and Collaboration Revenue [Member]
Total revenue

-

-

-

-

-

-

-

9,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Government Revenue [Member]
Total revenue

-

230

362

277

932

928

1,151

2,079

1,891

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible asset amortization [Member]
Cost of revenue

98

98

98

99

98

98

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-